These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 28230619)

  • 1. Population Pharmacokinetics of Topiramate in Japanese Pediatric and Adult Patients With Epilepsy Using Routinely Monitored Data.
    Takeuchi M; Yano I; Ito S; Sugimoto M; Yamamoto S; Yonezawa A; Ikeda A; Matsubara K
    Ther Drug Monit; 2017 Apr; 39(2):124-131. PubMed ID: 28230619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors influencing topiramate clearance in adult patients with epilepsy: A population pharmacokinetic analysis.
    Bae EK; Lee J; Shin JW; Moon J; Lee KJ; Shin YW; Kim TJ; Shin D; Jang IJ; Lee SK
    Seizure; 2016 Apr; 37():8-12. PubMed ID: 26908152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population Pharmacokinetic Modeling of Levetiracetam in Pediatric and Adult Patients With Epilepsy by Using Routinely Monitored Data.
    Ito S; Yano I; Hashi S; Tsuda M; Sugimoto M; Yonezawa A; Ikeda A; Matsubara K
    Ther Drug Monit; 2016 Jun; 38(3):371-8. PubMed ID: 26913593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A nonlinear mixed effects modelling analysis of topiramate pharmacokinetics in patients with epilepsy.
    Vovk T; Jakovljević MB; Kos MK; Janković SM; Mrhar A; Grabnar I
    Biol Pharm Bull; 2010; 33(7):1176-82. PubMed ID: 20606310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a population pharmacokinetic model for carbamazepine based on sparse therapeutic monitoring data from pediatric patients with epilepsy.
    Carlsson KC; Hoem NO; Glauser T; Vinks AA
    Clin Ther; 2005 May; 27(5):618-26. PubMed ID: 15978311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topiramate therapeutic monitoring in patients with epilepsy: effect of concomitant antiepileptic drugs.
    Contin M; Riva R; Albani F; Avoni P; Baruzzi A
    Ther Drug Monit; 2002 Jun; 24(3):332-7. PubMed ID: 12021622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population pharmacokinetics modeling of oxcarbazepine to characterize drug interactions in Chinese children with epilepsy.
    Wang Y; Zhang HN; Niu CH; Gao P; Chen YJ; Peng J; Liu MC; Xu H
    Acta Pharmacol Sin; 2014 Oct; 35(10):1342-50. PubMed ID: 25220641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population Pharmacokinetics of Topiramate in Patients with Epilepsy Using Nonparametric Modeling.
    Elewa M; Alghanem SS; Al-Hashel J; Thussu A; Al-Lanqawi Y; Matar K
    Ther Drug Monit; 2023 Dec; 45(6):797-804. PubMed ID: 37798835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic-pharmacodynamic assessment of topiramate dosing regimens for children with epilepsy 2 to <10 years of age.
    Girgis IG; Nandy P; Nye JS; Ford L; Mohanty S; Wang S; Ochalski S; Eerdekens M; Cox E
    Epilepsia; 2010 Oct; 51(10):1954-62. PubMed ID: 20880232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topiramate pharmacokinetics in children and adults with epilepsy: a case-matched comparison based on therapeutic drug monitoring data.
    Battino D; Croci D; Rossini A; Messina S; Mamoli D; Perucca E
    Clin Pharmacokinet; 2005; 44(4):407-16. PubMed ID: 15828853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population pharmacokinetics and dose simulation of oxcarbazepine in Chinese paediatric patients with epilepsy.
    Chen CY; Zhou Y; Cui YM; Yang T; Zhao X; Wu Y
    J Clin Pharm Ther; 2019 Apr; 44(2):300-311. PubMed ID: 30636182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population pharmacokinetics of oxcarbazepine active metabolite in Chinese children with epilepsy.
    Peng J; Zhang HN; Liu ZS; Xu H; Wang Y
    Int J Clin Pharmacol Ther; 2014 Aug; 52(8):684-92. PubMed ID: 24887335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population pharmacokinetics of topiramate in Chinese children with epilepsy.
    Wei S; Li X; Zhang Q; Wu H; Wu Y; Zhao Z; Mei S; Feng W
    Eur J Clin Pharmacol; 2023 Oct; 79(10):1401-1415. PubMed ID: 37597080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topiramate. Clinical profile in epilepsy.
    Sachdeo RC
    Clin Pharmacokinet; 1998 May; 34(5):335-46. PubMed ID: 9592618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topiramate: a new antiepileptic drug.
    Markind JE
    Am J Health Syst Pharm; 1998 Mar; 55(6):554-62. PubMed ID: 9544331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug interaction profile of topiramate.
    Bourgeois BF
    Epilepsia; 1996; 37 Suppl 2():S14-S17. PubMed ID: 8641241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population pharmacokinetic modeling of oxcarbazepine active metabolite in Chinese patients with epilepsy.
    Yu Y; Zhang Q; Xu W; Lv C; Hao G
    Eur J Drug Metab Pharmacokinet; 2016 Aug; 41(4):345-51. PubMed ID: 25700977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topiramate and phenytoin pharmacokinetics during repetitive monotherapy and combination therapy to epileptic patients.
    Sachdeo RC; Sachdeo SK; Levy RH; Streeter AJ; Bishop FE; Kunze KL; Mather GG; Roskos LK; Shen DD; Thummel KE; Trager WF; Curtin CR; Doose DR; Gisclon LG; Bialer M
    Epilepsia; 2002 Jul; 43(7):691-6. PubMed ID: 12102670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum concentrations of topiramate in patients with epilepsy: influence of dose, age, and comedication.
    May TW; Rambeck B; Jürgens U
    Ther Drug Monit; 2002 Jun; 24(3):366-74. PubMed ID: 12021627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic interactions of topiramate.
    Bialer M; Doose DR; Murthy B; Curtin C; Wang SS; Twyman RE; Schwabe S
    Clin Pharmacokinet; 2004; 43(12):763-80. PubMed ID: 15355124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.